Close Menu

Out of Academia

In a blog post at DeviceRandom, Massimo Sandal says why he left not only his chemistry postdoc at the University of Cambridge, but also why he chose to leave academia altogether. While he wasn't overly optimistic about his most recent research project, Sandal says he chose to leave the lab because he thinks there are problems within the "practice of science itself." While he says he still loves science, he's not so enamored with the high-stakes "competition for funding and positions" he's seen within it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.